FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207060313> ?p ?o ?g. }

• W4207060313 abstract "Abstract Background COVID-19 progression can be accompanied by a “cytokine storm” that leads to secondary sequelae such as thrombosis and acute respiratory distress syndrome. Several inflammatory cytokines have been associated with COVID-19 progression, but have far too much daily intra-individual variability to be useful in tracking the course of the disease. In contrast, we have shown that the inflammatory biomarker γ’ fibrinogen (γ’ Fbg) has a 6-fold lower coefficient of variability compared to other inflammatory markers such as hs-CRP. Objectives: The aims of the study were to measure γ’ Fbg in serial blood samples from COVID-19 patients at a tertiary care medical center in order to investigate its association with clinical measures of disease progression. Methods COVID-19 patients at a tertiary care medical center were retrospectively enrolled between 3/16/2020 and 8/1/2020. γ’ Fbg was measured using a commercial ELISA. Results: Our results showed that nine out of the seventeen patients with COVID-19 had extremely high levels of γ’ Fbg. γ’ Fbg levels were significantly associated with the need for ECMO and with mortality. Conclusions We found that COVID-19 patients can develop extraordinarily high levels of γ’ Fbg. The previous highest γ’ Fbg level that we are aware of was 80.3 mg/dL found in a study of 10,601 participants in the ARIC study. These results have several important clinical implications. γ’ Fbg contains a high affinity binding site for thrombin that binds to anion-binding exosite II on thrombin and protects it from inactivation by heparin. High levels of γ’ Fbg therefore provide a reservoir of heparin-resistant clot-bound thrombin when the γ’ Fbg is clotted. These findings have potential implications regarding prophylactic anticoagulation of COVID-19 patients and suggest that heparin prophylaxis may be less effective than using other anticoagulants, particularly direct thrombin inhibitors." @default.
• W4207060313 created "2022-01-26" @default.
• W4207060313 creator A5009195112 @default.
• W4207060313 creator A5015083291 @default.
• W4207060313 creator A5020013658 @default.
• W4207060313 creator A5020361487 @default.
• W4207060313 creator A5024576216 @default.
• W4207060313 creator A5034068693 @default.
• W4207060313 creator A5035425177 @default.
• W4207060313 creator A5067861844 @default.
• W4207060313 creator A5077894864 @default.
• W4207060313 creator A5091790990 @default.
• W4207060313 date "2022-01-21" @default.
• W4207060313 modified "2023-09-27" @default.
• W4207060313 title "Extreme γ’ fibrinogen levels in COVID-19 patients" @default.
• W4207060313 cites W1603365810 @default.
• W4207060313 cites W1982669495 @default.
• W4207060313 cites W1993780126 @default.
• W4207060313 cites W1999324640 @default.
• W4207060313 cites W2003843472 @default.
• W4207060313 cites W2055369991 @default.
• W4207060313 cites W2061069276 @default.
• W4207060313 cites W2066529692 @default.
• W4207060313 cites W2067058572 @default.
• W4207060313 cites W2068123793 @default.
• W4207060313 cites W2070151820 @default.
• W4207060313 cites W2077375327 @default.
• W4207060313 cites W2083010539 @default.
• W4207060313 cites W2090549428 @default.
• W4207060313 cites W2092608701 @default.
• W4207060313 cites W2134622396 @default.
• W4207060313 cites W2146619312 @default.
• W4207060313 cites W2229373161 @default.
• W4207060313 cites W3001118548 @default.
• W4207060313 cites W3009885589 @default.
• W4207060313 cites W3014001472 @default.
• W4207060313 cites W3081702754 @default.
• W4207060313 cites W3085661288 @default.
• W4207060313 cites W4324262907 @default.
• W4207060313 doi "https://doi.org/10.1101/2022.01.20.22269321" @default.
• W4207060313 hasPublicationYear "2022" @default.
• W4207060313 type Work @default.
• W4207060313 citedByCount "2" @default.
• W4207060313 countsByYear W42070603132023 @default.
• W4207060313 crossrefType "posted-content" @default.
• W4207060313 hasAuthorship W4207060313A5009195112 @default.
• W4207060313 hasAuthorship W4207060313A5015083291 @default.
• W4207060313 hasAuthorship W4207060313A5020013658 @default.
• W4207060313 hasAuthorship W4207060313A5020361487 @default.
• W4207060313 hasAuthorship W4207060313A5024576216 @default.
• W4207060313 hasAuthorship W4207060313A5034068693 @default.
• W4207060313 hasAuthorship W4207060313A5035425177 @default.
• W4207060313 hasAuthorship W4207060313A5067861844 @default.
• W4207060313 hasAuthorship W4207060313A5077894864 @default.
• W4207060313 hasAuthorship W4207060313A5091790990 @default.
• W4207060313 hasBestOaLocation W42070603131 @default.
• W4207060313 hasConcept C126322002 @default.
• W4207060313 hasConcept C185592680 @default.
• W4207060313 hasConcept C203014093 @default.
• W4207060313 hasConcept C2779036427 @default.
• W4207060313 hasConcept C2779134260 @default.
• W4207060313 hasConcept C2780868729 @default.
• W4207060313 hasConcept C2781197716 @default.
• W4207060313 hasConcept C2991842025 @default.
• W4207060313 hasConcept C3007834351 @default.
• W4207060313 hasConcept C3008058167 @default.
• W4207060313 hasConcept C524204448 @default.
• W4207060313 hasConcept C55493867 @default.
• W4207060313 hasConcept C71924100 @default.
• W4207060313 hasConcept C90924648 @default.
• W4207060313 hasConceptScore W4207060313C126322002 @default.
• W4207060313 hasConceptScore W4207060313C185592680 @default.
• W4207060313 hasConceptScore W4207060313C203014093 @default.
• W4207060313 hasConceptScore W4207060313C2779036427 @default.
• W4207060313 hasConceptScore W4207060313C2779134260 @default.
• W4207060313 hasConceptScore W4207060313C2780868729 @default.
• W4207060313 hasConceptScore W4207060313C2781197716 @default.
• W4207060313 hasConceptScore W4207060313C2991842025 @default.
• W4207060313 hasConceptScore W4207060313C3007834351 @default.
• W4207060313 hasConceptScore W4207060313C3008058167 @default.
• W4207060313 hasConceptScore W4207060313C524204448 @default.
• W4207060313 hasConceptScore W4207060313C55493867 @default.
• W4207060313 hasConceptScore W4207060313C71924100 @default.
• W4207060313 hasConceptScore W4207060313C90924648 @default.
• W4207060313 hasLocation W42070603131 @default.
• W4207060313 hasOpenAccess W4207060313 @default.
• W4207060313 hasPrimaryLocation W42070603131 @default.
• W4207060313 hasRelatedWork W3038506810 @default.
• W4207060313 hasRelatedWork W3135714043 @default.
• W4207060313 hasRelatedWork W3158785354 @default.
• W4207060313 hasRelatedWork W3164675712 @default.
• W4207060313 hasRelatedWork W3177945909 @default.
• W4207060313 hasRelatedWork W3198074937 @default.
• W4207060313 hasRelatedWork W3214513877 @default.
• W4207060313 hasRelatedWork W4220830958 @default.
• W4207060313 hasRelatedWork W4292583391 @default.
• W4207060313 hasRelatedWork W4311787753 @default.
• W4207060313 isParatext "false" @default.
• W4207060313 isRetracted "false" @default.
• W4207060313 workType "article" @default.